F-18-fluorodeoxiglucose positron emission tomography for the evaluation of neoadjuvant therapy response in esophageal cancer.
about
Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.Value of CT-PET after neoadjuvant chemoradiation in the prediction of histological tumour regression, nodal status and survival in oesophageal adenocarcinoma.
P2860
F-18-fluorodeoxiglucose positron emission tomography for the evaluation of neoadjuvant therapy response in esophageal cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
F-18-fluorodeoxiglucose positr ...... response in esophageal cancer.
@en
F-18-fluorodeoxiglucose positr ...... response in esophageal cancer.
@nl
type
label
F-18-fluorodeoxiglucose positr ...... response in esophageal cancer.
@en
F-18-fluorodeoxiglucose positr ...... response in esophageal cancer.
@nl
prefLabel
F-18-fluorodeoxiglucose positr ...... response in esophageal cancer.
@en
F-18-fluorodeoxiglucose positr ...... response in esophageal cancer.
@nl
P2093
P1433
P1476
F-18-fluorodeoxiglucose positr ...... response in esophageal cancer.
@en
P2093
Arnulf Hölscher
Elfriede Bollschweiler
Matthias Schmidt
P304
412-3; author reply 413
P356
10.1097/SLA.0B013E3181E9DFA0
P407
P577
2010-08-01T00:00:00Z